ATE344049T1 - Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes - Google Patents

Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes

Info

Publication number
ATE344049T1
ATE344049T1 AT02745850T AT02745850T ATE344049T1 AT E344049 T1 ATE344049 T1 AT E344049T1 AT 02745850 T AT02745850 T AT 02745850T AT 02745850 T AT02745850 T AT 02745850T AT E344049 T1 ATE344049 T1 AT E344049T1
Authority
AT
Austria
Prior art keywords
active ingredient
cyanidine
glycoside
diabetes
medicine containing
Prior art date
Application number
AT02745850T
Other languages
English (en)
Inventor
Takanori Tsuda
Fumihiko Horio
Toshihiko Osawa
Koji Uchida
Hiromitsu Aoki
Takatoshi Koda
Original Assignee
San Ei Gen Ffi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Ei Gen Ffi Inc filed Critical San Ei Gen Ffi Inc
Application granted granted Critical
Publication of ATE344049T1 publication Critical patent/ATE344049T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
AT02745850T 2002-02-28 2002-07-04 Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes ATE344049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002054286A JP2003252766A (ja) 2002-02-28 2002-02-28 シアニジン３−グルコシドを有効成分とする抗肥満及び／又は抗糖尿病剤

Publications (1)

Publication Number Publication Date
ATE344049T1 true ATE344049T1 (de) 2006-11-15

Family

ID=27764391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745850T ATE344049T1 (de) 2002-02-28 2002-07-04 Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes

Country Status (9)

Country Link
US (1) US20050084548A1 (de)
EP (1) EP1480663B1 (de)
JP (1) JP2003252766A (de)
AT (1) ATE344049T1 (de)
AU (1) AU2002317501A1 (de)
CA (1) CA2477555A1 (de)
DE (1) DE60215866T2 (de)
ES (1) ES2274053T3 (de)
WO (1) WO2003072121A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234957A1 (en) * 2003-03-03 2006-10-19 Takanori Tsuda Adiponectin expression promoter
EP1683805A4 (de) * 2003-10-24 2009-06-17 Meiji Seika Kaisha Neuer inhibitor für die bildung von advanced-glycation-endprodukten und aldosereduktaseinhibitor
WO2005082390A1 (ja) * 2004-03-02 2005-09-09 Asahi Breweries, Ltd. 脂肪蓄積抑制剤
JP4247833B2 (ja) * 2004-03-16 2009-04-02 株式会社ケーツーコミュニケーションズ 視機能改善剤
WO2006001278A1 (ja) * 2004-06-28 2006-01-05 Kao Corporation Ａｍｐｋ活性化剤
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
US7772195B2 (en) * 2004-07-29 2010-08-10 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
JP5111725B2 (ja) * 2004-10-21 2013-01-09 株式会社 バイオセラピー開発研究センター スイゼンジナを用いた医薬組成物
JP5118292B2 (ja) * 2005-06-16 2013-01-16 株式会社ロッテ 脂肪分解促進剤
US20070054965A1 (en) 2005-09-05 2007-03-08 Kao Corporation AMPK activating agent
ITRM20060233A1 (it) * 2006-04-28 2007-10-29 Angela Maria Amorini Metodo per la preparazione e l uso di un estratto arricchito in cianidina 3 o beta glucopiranoside e suoi derivati da frutti e vegetali conenti detta antocianina e per la purificazione e l uso di cianidina 3 o beta glucopiranoside e suoi derivati da
JP5201662B2 (ja) * 2007-02-28 2013-06-05 キッコーマン株式会社 血流改善組成物
US20090176718A1 (en) * 2007-10-31 2009-07-09 David Ribnicky Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome
FI20095144A0 (fi) * 2009-02-17 2009-02-17 Danisco Sugar Oy Elintarvikevalmiste
JP6105186B2 (ja) * 2009-04-22 2017-03-29 株式会社ブルボン 膵リパーゼ阻害剤
CN101933919B (zh) * 2010-07-01 2012-04-18 北京世纪博康医药科技有限公司 棕矢车菊素的用途
KR101322503B1 (ko) * 2010-10-11 2013-11-13 강원대학교산학협력단 맥문동 종자 추출물을 포함하는 항비만 조성물
KR101309137B1 (ko) 2011-08-30 2013-09-17 가톨릭대학교 산학협력단 Ｃ３ｇ 또는 이를 함유하는 오디 추출물을 포함하는 당뇨병성 발기부전의 예방 또는 치료용 조성물
JP2016175842A (ja) * 2013-08-12 2016-10-06 オリザ油化株式会社 Ｇｈｇ含有組成物及びそれを用いた脂肪吸収抑制剤
JP6364362B2 (ja) * 2015-02-17 2018-07-25 学校法人福岡大学 ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法
CN114081893A (zh) * 2021-10-11 2022-02-25 暨南大学 花色苷和果胶联用在制备预防和/或治疗非酒精性脂肪肝药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229439A (en) * 1977-11-21 1980-10-21 Societe De Recherches Industrielles (Sori) Method of treatment of atheroma
JP3334016B2 (ja) * 1994-07-15 2002-10-15 日研フード株式会社 抗糖尿病活性物質及び抗糖尿病合併症活性物質とその製造方法
ATE277613T1 (de) * 1995-12-26 2004-10-15 Suntory Ltd Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
JPH09291039A (ja) * 1995-12-26 1997-11-11 Suntory Ltd プロシアニジンを有効成分とする抗肥満剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
JPH11218572A (ja) * 1998-02-04 1999-08-10 Fuji Electric Co Ltd 超音波センサ
JP2000178295A (ja) * 1998-12-17 2000-06-27 Lion Corp 抗腫瘍組成物
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2001046030A (ja) * 1999-08-02 2001-02-20 Tama Seikagaku Kk ブルーベリー抽出エキスの製造法
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
AU2001229461A1 (en) * 2000-01-28 2001-08-07 Michigan State University Method for inhibiting a tumor
JP4549486B2 (ja) * 2000-04-26 2010-09-22 アピ株式会社 抗肥満薬及びその製造方法
US6780442B2 (en) * 2000-08-31 2004-08-24 Hauser, Inc. Efficient method for producing compositions enriched in anthocyanins

Also Published As

Publication number Publication date
EP1480663A1 (de) 2004-12-01
AU2002317501A1 (en) 2003-09-09
US20050084548A1 (en) 2005-04-21
CA2477555A1 (en) 2003-09-04
JP2003252766A (ja) 2003-09-10
WO2003072121A1 (en) 2003-09-04
EP1480663B1 (de) 2006-11-02
DE60215866T2 (de) 2007-06-21
DE60215866D1 (de) 2006-12-14
ES2274053T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
ATE344049T1 (de) Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes
DE60115498D1 (de) Chirurgische vorrichtungen
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
BRPI0509573A (pt) derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
ATE455547T1 (de) Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
WO2006055547A3 (en) Instrumented orthopedic and other medical implants
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
ATE339234T1 (de) Implantierbare medizinische vorrichtung und kissenelektrodensystem
CY1107752T1 (el) Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης
PH12013501791B1 (en) Uses of dpp-iv inhibitors
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
ATE363896T1 (de) Gegen missbrauch gesicherte darreichungsform
NO20065195L (no) Terapeutiske enzymformuleringer og anvendelser derav
NO20011174L (no) Nye heteroaromatiske inhibitorer av fruktose-1,6-bisfosfotase
BR9814698A (pt) Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
NO20053742L (no) Tri (cyclo)-substituerte amidforbindelser
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
WO2003101397A3 (en) Tetravalent dengue vaccines
ATE434639T1 (de) Wässrige dispersionen von silikon-polyether- blockcopolymeren
MXPA03006364A (es) TRATAMIENTO DE PERTURBACIONES DEL SUEnO.
HUP0300725A2 (hu) Az inzulinrezisztencia-szindróma kezelése CGMP PDE5 inhibitorokkal
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties